An open label study to assess the efficacy of losartan/HCTZ [hydrochlorothiazide] combination therapy in patients with essential hypertension who were inadequately controlled on current antihypertensive monotherapy
Phase of Trial: Phase III
Latest Information Update: 12 May 2017
At a glance
- Drugs Losartan/hydrochlorothiazide (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Acronyms HEAALTH
- Sponsors Merck Sharp & Dohme
- 25 Jul 2007 The expected completion date for this trial is now 1 Apr 2007.
- 12 Feb 2007 Status change
- 28 Sep 2006 New trial record.